Market Insights Consumer OTC Pharmaceuticals

Wound Care - Europe

Europe

Revenue in the Wound Care market amounts to €1.12bn in 2024. The market is expected to grow annually by 0.35% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€961m in 2024).
In relation to total population figures, per person revenues of €1.33 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in Europe is experiencing significant growth due to several factors. Customer preferences for advanced wound care products, increasing prevalence of chronic wounds, and the aging population are driving the demand for wound care products in the region.

Customer preferences in Europe are shifting towards advanced wound care products that offer faster healing, reduced pain, and improved patient comfort. This trend is driven by the increasing awareness among healthcare professionals and patients about the benefits of advanced wound care products. Additionally, the demand for products that promote wound healing and prevent infection is also on the rise.

As a result, manufacturers are focusing on developing innovative wound care products to meet the evolving customer preferences in the region. The prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is increasing in Europe. This is primarily attributed to the aging population and the rising incidence of chronic diseases, such as diabetes and obesity.

Chronic wounds require specialized wound care products and treatments for effective management. As a result, the demand for wound care products is growing in Europe. The aging population in Europe is another significant factor contributing to the growth of the wound care market.

As people age, their skin becomes more susceptible to injuries and wounds. Moreover, the aging population is more prone to chronic diseases, which further increases the risk of developing wounds. The need for wound care products is higher among the elderly population, driving the market growth in Europe.

In addition to customer preferences and demographic factors, local special circumstances in Europe also impact the wound care market. The presence of a well-established healthcare infrastructure and reimbursement systems in many European countries supports the adoption of advanced wound care products. Moreover, the increasing focus on cost-effective healthcare solutions and the emphasis on reducing hospital-acquired infections are driving the demand for wound care products in the region.

Underlying macroeconomic factors, such as GDP growth and healthcare expenditure, also play a role in the development of the wound care market in Europe. The overall economic stability and increasing healthcare spending in the region contribute to the growth of the market. Additionally, favorable government initiatives and policies aimed at improving healthcare facilities and reducing healthcare costs further support the growth of the wound care market in Europe.

Overall, the Wound Care market in Europe is witnessing growth due to customer preferences for advanced wound care products, increasing prevalence of chronic wounds, the aging population, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as manufacturers focus on innovation and healthcare systems strive to provide effective and cost-efficient wound care solutions.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.